Oramed to Present at the 83rd American Diabetes Association Conference
Provided By PR Newswire
Last update: Jun 20, 2023
NEW YORK, June 20, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that it has been selected to present an oral abstract presentation at the American Diabetes Association's 83rd Scientific Sessions, taking place between June 23-26, 2023 in San Diego, California.
Read more at prnewswire.com2
-0.09 (-4.31%)
Find more stocks in the Stock Screener
ORMP Latest News and Analysis
19 days ago - ChartmillUnusual volume stocks in Wednesday's sessionDiscover the stocks with unexpected trading volume in today's session on the US markets.
20 days ago - ChartmillWhat's going on in today's sessionKeep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
